↓ Skip to main content

Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis

Overview of attention for article published in PharmacoEconomics, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

policy
1 policy source

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
39 Mendeley
Title
Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis
Published in
PharmacoEconomics, September 2012
DOI 10.2165/00019053-200624010-00007
Pubmed ID
Authors

Antonio Gómez-Outes, Eduardo Rocha, Javier Martínez-González, Vijay V. Kakkar

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 21%
Other 6 15%
Student > Master 6 15%
Student > Ph. D. Student 4 10%
Student > Doctoral Student 3 8%
Other 4 10%
Unknown 8 21%
Readers by discipline Count As %
Medicine and Dentistry 15 38%
Pharmacology, Toxicology and Pharmaceutical Science 5 13%
Economics, Econometrics and Finance 3 8%
Social Sciences 3 8%
Nursing and Health Professions 2 5%
Other 1 3%
Unknown 10 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2020.
All research outputs
#7,512,050
of 22,947,506 outputs
Outputs from PharmacoEconomics
#885
of 1,855 outputs
Outputs of similar age
#56,586
of 171,228 outputs
Outputs of similar age from PharmacoEconomics
#14
of 57 outputs
Altmetric has tracked 22,947,506 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,855 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,228 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.